España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
IGC Pharma
IGC
AMEX
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.3434
0.00350
1.03%
At close: -
Get Report
Comment
IGC Pharma (IGC) Forecast
News
Earnings
IGC Pharma (IGC) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for IGC Pharma (AMEX:IGC) Stock
IGC Pharma Stock (AMEX: IGC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, January 21, 2025
IGC Pharma Appoints Former VA Governor Terry ...
Benzinga Newsdesk
Wednesday, January 08, 2025
IGC Pharma Names Alzheimer's Agitation Phase ...
Benzinga Newsdesk
Thursday, December 05, 2024
Ascendiant Capital Maintains Buy on IGC Pharm...
Benzinga Newsdesk
Monday, December 02, 2024
IGC Pharma Initiates New Trials To Evaluate I...
Benzinga Newsdesk
Wednesday, November 27, 2024
'DEA Judge Won't Remove Agency From Marijuana...
Benzinga Newsdesk
Tuesday, November 26, 2024
DEA Says Formal Hearing Proceedings Regarding...
Benzinga Newsdesk
'Federal Health Officials 'Rejected' DEA's Re...
Benzinga Newsdesk
'Democratic Congressional Lawmakers Push Bide...
Benzinga Newsdesk
Cannabinoid Drug For Agitation In Alzheimer's Yields Cognitive Improvements In Clinical Trial
Nina Zdinjak
Monday, November 25, 2024
Tom Angell Says "DEA says it is in the proces...
Benzinga Newsdesk
IGC Pharma Announces Additional Phase 2 Inter...
Benzinga Newsdesk
Thursday, November 14, 2024
IGC Pharma Q2 EPS $(0.02) Beats $(0.03) Estim...
Benzinga Newsdesk
Wednesday, November 13, 2024
'Newly Elected Republican Senate Majority Lea...
Benzinga Newsdesk
Wednesday, November 06, 2024
IGC Pharma Announces Publication Of IMS Spotl...
Benzinga Newsdesk
Tuesday, October 22, 2024
"Legislative Committee In Ireland Calls For M...
Benzinga Newsdesk
Tuesday, October 01, 2024
Lawmakers Urge DEA To Finalize Marijuana Resc...
Benzinga Newsdesk
Monday, September 30, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Shares of cannabis stocks are trading higher ...
Benzinga Newsdesk
"Kamala Harris Says 'We Need To Legalize' Mar...
Benzinga Newsdesk
Friday, September 27, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
IGC Pharma shares are trading higher after a ...
Benzinga Newsdesk
IGC Pharma From4 Filing Shows Company Directo...
Benzinga Newsdesk
Thursday, September 26, 2024
"National Agriculture Regulators Group Grappl...
Benzinga Newsdesk
Monday, September 23, 2024
'DEA Calls For Massive Increases In Psilocybi...
Benzinga Newsdesk
Wednesday, September 18, 2024
IGC Pharma Says IGC-AD1 Demonstrated Potentia...
Benzinga Newsdesk
Wednesday, September 04, 2024
IGC Pharma Advances Proprietary Alzheimer's T...
Benzinga Newsdesk
Tuesday, September 03, 2024
The Analyst Verdict: IGC Pharma In The Eyes Of 4 Experts
Benzinga Insights
Ascendiant Capital Maintains Buy on IGC Pharm...
Benzinga Newsdesk
Thursday, August 22, 2024
IGC Pharma's Preclinical Research Highlights ...
Benzinga Newsdesk
Tuesday, August 20, 2024
IGC Pharma Says IGC-1A Has Been Identified As...
Benzinga Newsdesk
Tuesday, August 13, 2024
'Trump Endorsing Florida Marijuana Legalizati...
Benzinga Newsdesk
Friday, August 09, 2024
IGC Pharma Revenue Declines 51% YoY Due To Completion Of Its Legacy Project In India, Highlights Important Milestones In Alzheimer's Research
Nina Zdinjak
IGC Pharma Q1 2025 GAAP EPS $(0.03), Inline, ...
Benzinga Newsdesk
Monday, July 29, 2024
Ascendiant Capital Maintains Buy on IGC Pharm...
Benzinga Newsdesk
Wednesday, July 17, 2024
President Biden X Post Says "I'm making sure ...
Benzinga Newsdesk
Alliance Global Partners Initiates Coverage O...
Benzinga Newsdesk
Tuesday, July 09, 2024
'GOP Congressional Committee Approves Bill To...
Benzinga Newsdesk
IGC Pharma Preliminary Preclinical Analyses O...
Benzinga Newsdesk
Monday, July 08, 2024
'California Legislature Approves Bill To Brea...
Benzinga Newsdesk
Tuesday, June 25, 2024
IGC Pharma Annonuces Mouse Studies Showing Re...
Benzinga Newsdesk
IGC Pharma Q4 2024 GAAP EPS $(0.04), Sales $2...
Benzinga Newsdesk
Friday, June 21, 2024
Ascendiant Capital Reiterates Buy on IGC Phar...
Benzinga Newsdesk
Thursday, June 13, 2024
Hedge Fund Settles At $2.25M With SEC For Exposed Short Seller Deal, 2 Cannabis Stocks Affected
Rolando García
Tuesday, June 11, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Monday, June 10, 2024
IGC Pharma Publishes Study In European Societ...
Benzinga Newsdesk
Tuesday, June 04, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Friday, May 31, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Tuesday, May 28, 2024
IGC Pharma Announces Patient Enrollment At Ne...
Benzinga Newsdesk
Thursday, May 16, 2024
'Justice Department Poised To Post Plans For ...
Benzinga Newsdesk
Friday, May 10, 2024
'DEA Appears To Question Marijuana's Medical ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
